(VegasInc) Doctors at the Cleveland Clinic Lou Ruvo Center for Brain Health have a grim message to share with the public: We're not doing enough to develop drugs to battle Alzheimer's disease.
The center set out this year to analyze all clinical trials of drugs tested on Alzheimer's patients in the United States. The researchers' findings: only 244 drugs have been tested in the past decade. The failure rate for Alzheimer's drugs awaiting approval was 99.6 percent between 2002 and 2012, the Ruvo Center found.
"This is a kind of shock; we really have to reconsider this because the failure rate is unacceptably high," said Dr. Jeffrey Cummings, director of the center's clinical trials. "We're simply not meeting the challenge. We're going to have to invest much more into the drug development process."
Advertisement - story continues below